Literature DB >> 19682504

Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta.

Vanessa M Banz1, Michaela Medová, Adrian Keogh, Cynthia Furer, Yitzhak Zimmer, Daniel Candinas, Deborah Stroka.   

Abstract

N-myc downstream-regulated gene 1 (NRDG1) is a stress-induced protein whose putative function is suppression of tumor metastasis. A recent proteonomic study showed NDRG1 interacts with the molecular chaperone heat shock protein 90 (Hsp90). From their reported association, we investigated if NDRG1 is dependent on Hsp90 for its stability and is therefore a yet unidentified Hsp90 client protein. Here, we demonstrate that endogenous NDRG1 and Hsp90 physically associate in hepatocellular cancer cell lines. However, geldanamycin (GA)-mediated inhibition of Hsp90 did not disrupt their interaction or result in NDRG1 protein destabilization. On the contrary, inhibition of Hsp90 led to a transcriptional increase of NDRG1 protein which was associated with cell growth arrest. We also observed that GA inhibited the phosphorylation of NDRG1 by targeting its regulating kinases, serum- and glucocorticoid-induced kinase 1 (SGK1) and glycogen synthase kinase 3 beta (GSK3beta). We demonstrate that in the presence of GA, GSK3beta protein and activity were decreased thus indicating that Hsp90 is necessary for GSK3beta stability. Taken together, our data demonstrate that NDRG1 is not a classic client protein but interacts with Hsp90 and is still dually regulated by Hsp90 at a transcriptional and post-translational level. Finally, we suggest for the first time GSK3beta as a new client protein of Hsp90.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682504     DOI: 10.1016/j.bbamcr.2009.08.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.

Authors:  Xiaojing Chang; Xiaoyang Xu; Xiaoying Xue; Jinguo Ma; Zhenhua Li; Peng Deng; Jing Chen; Shuanglong Zhang; Yu Zhi; Dongqiu Dai
Journal:  Pathol Oncol Res       Date:  2016-05-06       Impact factor: 3.201

2.  Characterization of TsDAF-21/HSP90 protein from the parasitic nematode Trichinella spiralis.

Authors:  Yurong Yang; Weiwen Qin; Hengtong Qiu; Yan Liu
Journal:  Parasitol Res       Date:  2014-04-08       Impact factor: 2.289

3.  Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.

Authors:  Eliane Angst; David W Dawson; Anne Nguyen; Jenny Park; Vay L W Go; Howard A Reber; Oscar Joe Hines; Guido Eibl
Journal:  Pancreas       Date:  2010-07       Impact factor: 3.327

4.  NDRG1 deficiency attenuates fetal growth and the intrauterine response to hypoxic injury.

Authors:  Jacob Larkin; Baosheng Chen; Xiao-Hua Shi; Takuya Mishima; Koichi Kokame; Yaacov Barak; Yoel Sadovsky
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

Review 5.  Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.

Authors:  Yunpeng Huang; Zhihao Wu; Bing Zhou
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 6.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.

Authors:  Pratikkumar H Vekaria; Amar Kumar; Dharmalingam Subramaniam; Neil Dunavin; Anusha Vallurupalli; Frank Schoenen; Siddhartha Ganguly; Shrikant Anant; Joseph P McGuirk; Roy A Jensen; Rekha Rao
Journal:  Leukemia       Date:  2019-01-21       Impact factor: 11.528

8.  Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS-Mutant NSCLC Is Mediated via Reactivation of the ERK-p90RSK-mTOR Signaling Network.

Authors:  Suman Chatterjee; Eric H-B Huang; Ian Christie; Brenda F Kurland; Timothy F Burns
Journal:  Mol Cancer Ther       Date:  2017-02-06       Impact factor: 6.261

9.  Use of kinase inhibitors to correct ΔF508-CFTR function.

Authors:  Agata M Trzcinska-Daneluti; Leo Nguyen; Chong Jiang; Christopher Fladd; David Uehling; Michael Prakesch; Rima Al-awar; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2012-06-14       Impact factor: 7.381

10.  Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells.

Authors:  Mohammad K Ghalayini; Qihan Dong; Des R Richardson; Stephen J Assinder
Journal:  Biosci Rep       Date:  2013-06-11       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.